Patents by Inventor Stephanie Lynn Ciarlone

Stephanie Lynn Ciarlone has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Ketone supplements for treatment of angelman syndrome
    Patent number: 9795580
    Abstract: The invention concerns a method of treating Angelman Syndrome (AS) in a subject, comprising inducing ketosis in the subject by administering a therapeutically effective amount of a ketone ester, such as an R,S-1,3-butanediol acetoacetate ester, wherein administration of the ketone ester elevates the blood ketone level in the subject. Other aspects of the invention include a method of increasing cognitive function and/or motor function in a subject with AS; and a method of decreasing seizures and increasing the latency to seize in a subject with AS.
    Type: Grant
    Filed: May 24, 2016
    Date of Patent: October 24, 2017
    Assignee: UNIVERSITY OF SOUTH FLORIDA
    Inventors: Edwin John Weeber, Stephanie Lynn Ciarlone, Dominic Paul D'Agostino
  • KETONE SUPPLEMENTS FOR TREATMENT OF ANGELMAN SYNDROME
    Publication number: 20170000754
    Abstract: The invention concerns a method of treating Angelman Syndrome (AS) in a subject, comprising inducing ketosis in the subject by administering a therapeutically effective amount of a ketone ester, such as an R,S-1,3-butanediol acetoacetate ester, wherein administration of the ketone ester elevates the blood ketone level in the subject. Other aspects of the invention include a method of increasing cognitive function and/or motor function in a subject with AS; and a method of decreasing seizures and increasing the latency to seize in a subject with AS.
    Type: Application
    Filed: May 24, 2016
    Publication date: January 5, 2017
    Applicant: UNIVERSITY OF SOUTH FLORIDA
    Inventors: EDWIN JOHN WEEBER, STEPHANIE LYNN CIARLONE, DOMINIC PAUL D'AGOSTINO
  • Ketone esters for treatment of angelman syndrome
    Patent number: 9364456
    Abstract: The invention concerns a method of treating Angelman Syndrome (AS) in a subject, comprising inducing ketosis in the subject by administering a therapeutically effective amount of a ketone ester, such as an R,S-1,3-butanediol acetoacetate ester, wherein administration of the ketone ester elevates the blood ketone level in the subject. Other aspects of the invention include a method of increasing cognitive function and/or motor function in a subject with AS; and a method of decreasing seizures and increasing the latency to seize in a subject with AS.
    Type: Grant
    Filed: June 30, 2015
    Date of Patent: June 14, 2016
    Assignee: UNIVERSITY OF SOUTH FLORIDA
    Inventors: Edwin John Weeber, Stephanie Lynn Ciarlone, Dominic Paul D'Agostino